<![CDATA[Insights]]>https://insights.citeline.comTue, 12 Nov 2024 09:40:27 +0000en1hourly1<![CDATA[Looking For STARs: US FDA Expands Split Real Time Review Amid Low Supplement Interest]]>https://insights.citeline.com/pink-sheet/pathways-and-standards/review-pathways/looking-for-stars-us-fda-expands-split-real-time-review-amid-low-supplement-interest-V5SRGEVE4RCXLO5TERLIK4RFBI/https://insights.citeline.com/pink-sheet/pathways-and-standards/review-pathways/looking-for-stars-us-fda-expands-split-real-time-review-amid-low-supplement-interest-V5SRGEVE4RCXLO5TERLIK4RFBI/Mon, 11 Nov 2024 21:56:35 +0000<![CDATA[Chinese Regulator Raises Red Flag On Clinical Trial Bribery]]>https://insights.citeline.com/pink-sheet/compliance/marketing-and-advertising/chinese-regulator-raises-red-flag-on-clinical-trial-bribery-6SHO5XBFURF4PIGJJ4ONKAP7XU/https://insights.citeline.com/pink-sheet/compliance/marketing-and-advertising/chinese-regulator-raises-red-flag-on-clinical-trial-bribery-6SHO5XBFURF4PIGJJ4ONKAP7XU/Tue, 12 Nov 2024 00:03:29 +0000<![CDATA[Japan Recommends Approval Of Brukinza, Balversa]]>https://insights.citeline.com/pink-sheet/japan-recommends-approval-of-brukinza-balversa-7KRG7Y3IEVFFLD27P6TZVEUD4U/https://insights.citeline.com/pink-sheet/japan-recommends-approval-of-brukinza-balversa-7KRG7Y3IEVFFLD27P6TZVEUD4U/Mon, 11 Nov 2024 05:12:11 +0000<![CDATA[Woodcock On Proposed Rare Rx Approval Pathway: US FDA’s Current Flexibilities Come Too Late]]>https://insights.citeline.com/pink-sheet/rare-diseases/woodcock-on-new-rare-rx-approval-pathway-us-fdas-current-flexibilities-come-too-late-3CNIRTHQBFDPLL7VK56TCBUJ5E/https://insights.citeline.com/pink-sheet/rare-diseases/woodcock-on-new-rare-rx-approval-pathway-us-fdas-current-flexibilities-come-too-late-3CNIRTHQBFDPLL7VK56TCBUJ5E/Mon, 11 Nov 2024 22:04:05 +0000<![CDATA[UK Toolkit To Accelerate Research Set-Up Across England, NI, Scotland And Wales ]]>https://insights.citeline.com/pink-sheet/uk-toolkit-to-accelerate-research-set-up-across-england-ni-scotland-wales-FPOUNPTWKVDHNLFROTMOATKYHU/https://insights.citeline.com/pink-sheet/uk-toolkit-to-accelerate-research-set-up-across-england-ni-scotland-wales-FPOUNPTWKVDHNLFROTMOATKYHU/Mon, 11 Nov 2024 13:04:14 +0000<![CDATA[Anticipation And Trepidation About Trump’s Election Rise ]]>https://insights.citeline.com/pink-sheet/legislation/elections/anticipation-and-trepidation-about-trumps-election-rise-YTCHNKQW4VA3PPY3GBF3BQLAOQ/https://insights.citeline.com/pink-sheet/legislation/elections/anticipation-and-trepidation-about-trumps-election-rise-YTCHNKQW4VA3PPY3GBF3BQLAOQ/Mon, 11 Nov 2024 21:58:36 +0000<![CDATA[UK MHRA: ‘At Least Half’ Of Novel Drug Filings To Take National Assessment Route ]]>https://insights.citeline.com/pink-sheet/agency-leadership/uk-mhra-at-least-half-of-novel-drug-filings-to-take-national-assessment-route-P537X5RTI5CUHBUINYQHWC6SPI/https://insights.citeline.com/pink-sheet/agency-leadership/uk-mhra-at-least-half-of-novel-drug-filings-to-take-national-assessment-route-P537X5RTI5CUHBUINYQHWC6SPI/Mon, 11 Nov 2024 14:18:25 +0000